Nathan T. Ross

2.0k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Nathan T. Ross is a scholar working on Molecular Biology, Organic Chemistry and Clinical Biochemistry. According to data from OpenAlex, Nathan T. Ross has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Clinical Biochemistry. Recurrent topics in Nathan T. Ross's work include Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nathan T. Ross is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nathan T. Ross collaborates with scholars based in United States, Germany and Italy. Nathan T. Ross's co-authors include Andrew D. Hamilton, William P. Katt, Benjamin L. Miller, Rashid Deane, Sheldon Perry, Robert D. Bell, Alan E. Friedman, G. Fritz, Rachal Love and Nicole Paquette and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Nathan T. Ross

25 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease

2012 510 citations Rashid Deane, Itender Singh et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Nathan T. Ross

Since Specialization

Citations

This map shows the geographic impact of Nathan T. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan T. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan T. Ross more than expected).

Fields of papers citing papers by Nathan T. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan T. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan T. Ross. The network helps show where Nathan T. Ross may publish in the future.

Co-authorship network of co-authors of Nathan T. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan T. Ross. A scholar is included among the top collaborators of Nathan T. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan T. Ross. Nathan T. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program 2024 ·Molecular Genetics and Metabolism ·(unknown), Eliza Kruger, David Yin, (unknown), (unknown), (unknown), (unknown), (unknown), Nathan T. Ross, Kathleen L. Deering, (unknown), Qing Harshaw, Alicia C. Shillington, (unknown), Deborah Marsden, Amy Kritzer, Jerry Vockley	6
2	eP495: Introduction to Odyssey: Real-world rare disease data collection program for patients with long-chain fatty acid oxidation disorders in the US 2022 ·Genetics in Medicine ·Eliza Kruger, (unknown), (unknown), (unknown), Kieran Mace, (unknown), (unknown), (unknown), Nathan T. Ross, Amy Kritzer	1
3	A Novel Luminescence-Based High-Throughput Approach for Cellular Resolution of Protein Ubiquitination Using Tandem Ubiquitin Binding Entities (TUBEs) 2020 ·SLAS DISCOVERY ·(unknown), Aleem Fazal, Marc Hild, Rohan E. J. Beckwith, Nathan T. Ross, Joshiawa Paulk, Seth Carbonneau	6
4	Art as Human Practice 2019 ·Bloomsbury Academic eBooks ·(unknown), Nathan T. Ross	3
5	Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Seth Carbonneau, Nathan T. Ross	8
6	Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex 2015 ·eLife ·Jordan D. Carelli, Steven G. Sethofer, Geoffrey A. Smith, Howard Miller, (unknown), William C. Merrick, Rishi K. Jain, Nathan T. Ross, Jack Taunton	42
7	In vitro clinical trials: the future of cell-based profiling 2014 ·Frontiers in Pharmacology ·Nathan T. Ross, Christopher J. Wilson	13
8	Identification of small molecules for human hepatocyte expansion and iPS differentiation 2013 ·Nature Chemical Biology ·Jing Shan, Robert E. Schwartz, Nathan T. Ross, David J. Logan, David Thomas, Stephen A. Duncan, Trista E. North, Wolfram Goessling, Anne E. Carpenter, Sangeeta N. Bhatia	4
9	A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease breakdown → 2012 ·Journal of Clinical Investigation ·Rashid Deane, Itender Singh, Abhay P. Sagare, Robert D. Bell, Nathan T. Ross, (unknown), Rachal Love, Sheldon Perry, Nicole Paquette, (unknown), Meenakshisundaram Thiyagarajan, Troy J. Zarcone, G. Fritz, Alan E. Friedman, Benjamin L. Miller, Berislav V. Zloković	510
10	A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells 2012 ·ACS Medicinal Chemistry Letters ·Michel Weïwer, James Spoonamore, Jingqiang Wei, (unknown), Nathan T. Ross, Kristina Masson, Whitney Silkworth, Sivaraman Dandapani, Michelle Palmer, Christina Scherer, Andrew M. Stern, Stuart L. Schreiber, Benito Muñoz	115
11	STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability 2012 ·Proceedings of the National Academy of Sciences ·Tuoping Luo, Kristina Masson, Jacob D. Jaffe, Whitney Silkworth, Nathan T. Ross, Christina Scherer, Claudia Scholl, Stefan Fröhling, Steven A. Carr, Andrew M. Stern, Stuart L. Schreiber, Todd R. Golub	65
12	Synthetic mimetics of protein secondary structure domains 2010 ·Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences ·Nathan T. Ross, William P. Katt, Andrew D. Hamilton	62
13	Synthetic Inhibitors of Extended Helix–Protein Interactions Based on a Biphenyl 4,4′‐Dicarboxamide Scaffold 2009 ·ChemBioChem ·Johanna M. Rodriguez, Laura Nevola, Nathan T. Ross, Gui‐in Lee, Andrew D. Hamilton	33
14	Structure and Function of Benzoylurea‐Derived α‐Helix Mimetics Targeting the Bcl‐x_L/Bak Binding Interface 2009 ·ChemMedChem ·Johanna M. Rodriguez, Nathan T. Ross, William P. Katt, (unknown), Gui‐in Lee, Andrew D. Hamilton	40
15	Multivalent Protein Binding and Precipitation by Self-Assembling Molecules on a DNA Pentaplex Scaffold 2009 ·Journal of the American Chemical Society ·(unknown), Nathan T. Ross, Debarati M. Tagore, Janarthanan Jayawickramarajah, Ishu Saraogi, Andrew D. Hamilton	52
16	Biophysical analysis of the EPEC translocated intimin receptor-binding domain 2007 ·Biochemical and Biophysical Research Communications ·Nathan T. Ross, Charles R. Mace, Benjamin L. Miller	6
17	Characterization of the binding surface of the translocated intimin receptor, an essential protein for EPEC and EHEC cell adhesion 2007 ·Protein Science ·Nathan T. Ross, Benjamin L. Miller	7
18	Single-Step Synthesis of Functional Organic Receptors via a Tridirectional Minisci Reaction 2007 ·Synthesis ·Benjamin L. Miller, Prakash B. Palde, (unknown), Nathan T. Ross, Peter C. Gareiss, Charles R. Mace, (unknown)	2
19	Single‐Step Synthesis of Functional Organic Receptors via a Tridirectional Minisci Reaction. 2007 ·ChemInform ·Prakash B. Palde, (unknown), Nathan T. Ross, Peter C. Gareiss, Charles R. Mace, (unknown), Benjamin L. Miller	0
20	Biology and control ofAgrobacterium tumefaciens 1971 ·Hilgardia ·M. N. Schroth, A. R. Weinhold, (unknown), D. C. Hildebrand, Nathan T. Ross	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact